Press Releases Archives - Page 3 of 103 - Lupin

BSE 2300.00 NSE 2307.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2300.00 NSE 2307.90

Lupin Bioresearch Center Receives Zero Observations from U.S. FDA After Successful Inspection and Assessment

November 8, 2025

Lupin Q2 FY2026 Results

November 6, 2025

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-3 Facility

November 5, 2025

Lupin Digital Health Launches VITALYFE™

October 30, 2025

Governor Murphy and Local Leaders Attend Ribbon-Cutting Ceremony, Marking the Inauguration of Lupin’s New Corporate Offices in Bridgewater

October 28, 2025

Lupin Launches Authorized Generic Version of Ravicti® in the United States

October 24, 2025

Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025

October 13, 2025

Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform

October 9, 2025

Lupin Announces  Plans to Build a  New  State-of-the-Art  Manufacturing  Facility in Coral Springs, Florida  Extending its Long-Standing Commitment to America’s Patients and Healthcare System  

October 8, 2025

Lupin Launches Liraglutide Injection in the United States

October 3, 2025

1 2 3 4 … 102 103

Search

Hit enter to search or ESC to close